Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival

Danish Medical Journal

Volumn 61, Issue 1, 2014, Pages

  Storkholm, Jan Henrik ^a   Hansen, Carsten Palnæs ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; BILE LEAKAGE; BLEEDING; BLOOD VESSEL GRAFT; CANCER STAGING; CHOLANGITIS; CHOLESTASIS; CHYLOUS ASCITES; COMPUTER ASSISTED TOMOGRAPHY; END TO END ANASTOMOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PNEUMONIA; PORTAL VEIN; RISK ASSESSMENT; SAFETY; SUPERIOR MESENTERIC VEIN; SURGICAL MORTALITY; VASCULAR CLAMP; VEIN SURGERY; VERY ELDERLY; WOUND DEHISCENCE; WOUND INFECTION; ADENOCARCINOMA; ANASTOMOSIS; DUODENUM TUMOR; EVALUATION STUDY; KAPLAN MEIER METHOD; MESENTERIC VEIN; MORTALITY; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; CARCINOMA, PANCREATIC DUCTAL; DUODENAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MESENTERIC VEINS; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR GRAFTING;

EID: 84891789902     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
2. Jemal A, Siegel R, Ward E et al. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Ferrone CR, Brennan MF, Gonen M et al. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg 2008;12:701-6.
4. Hackert T, Büchler MW. Pancreatic cancer: advances in treatment, results and limitations. Dig Dis 2013;31:51-6.
5. Mollberg N, Rahbari NN, Koch M et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and metaanalysis. Ann Surg 2011;254:882-93.
6. Kurosaki I, Hatakeyama K, Minagawa M et al. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. Gastrointest Surg 2008;12:907-18.
7. Carrere N, Sauvanet A, Goere D et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg 2006;30:1526-35.
8. Han SS, Park SJ, Kim SH et al. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer. Pancreas 2012;41:102-6.
9. Rehders A, Stoecklein NH, Güray A et al. Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery 2012;152(3 suppl 1):S143-S151.
10. Ramacciato G, Mercantini P, Petrucciani N et al. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 2009;16:817-25.
11. Fortner JG, Kim DK, Cubilla A et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977;186:42-50.
12. Kræftstatistik: nøgletal og figurer Danmark-bugspytkirtel. www-dep.iarc. fr/NORDCAN/DK/PDF/FS_130-208.pdf
13. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual. New York: Springer, 2010.
14. Verbeke CS, Leitch D, Menon KV et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232-7.
15. Weitz J, Rahbari N, Koch M et al. The "artery first" approach for resection of pancreatic head cancer. J Am Coll Surg 2010;210:e1-e4.
16. Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006;93:662-73.
17. Banz VM, Croagh D, Coldham C et al. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas. Eur J Surg Oncol 2012;38:72-9.
18. Effenberger KE, Schroeder C, Eulenburg C et al. Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. Int J Cancer 2012;131:E475-E483.
19. Scheunemann P, Stoecklein NH, Rehders A et al. Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater. HPB (Oxford) 2007;9:135-9.
20. Turrini O, Ewald J, Barbier L et al. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg 2013;257:726-30.